Martin Steegmaier

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo

Martin Steegmaier, Matthias Hoffmann, Anke Baum et al. · Current Biology · 2007 · 839 citations · Full text

Tumor Biology, Bi 2536, Medicine +9

The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1

Péter Lénárt, Mark Petronczki, Martin Steegmaier et al. · Current Biology · 2007 · 675 citations · Full text

Signal Transduction, Mitotic Roles, Cell Division +12

BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity

Dorothea Rudolph, Martin Steegmaier, Matthias Hoffmann et al. · Clinical Cancer Research · 2009 · 388 citations · Full text

SNARE Interactions Are Not Selective

Bin Yang, Lino C. Gonzalez, Rytis Prekeris et al. · Journal of Biological Chemistry · 1999 · 315 citations · Full text

Membrane Fusion, Snare Hypothesis, Proteinlipid Interaction +14

BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms<i>in vitro</i>and<i>in vivo</i>

Gopal P. Sapkota, Lorna Cummings, Felicity Newell et al. · Biochemical Journal · 2006 · 301 citations · Full text

Specific Inhibitor, Small Molecule Bi-d1870, Immunology +21